Use of Rapid Antigen Detection Tests Versus Viral Culture in De-isolation Decision-Making for Critically Ill Patients Infected with Omicron B.1.1.529

[1]  Clinical progression, disease severity, and mortality among adults hospitalized with COVID-19 caused by the Omicron and Delta SARS-CoV-2 variants: A population-based, matched cohort study , 2023, PloS one.

[2]  Y. Jouan,et al.  The positive impact of COVID-19 on critical care: from unprecedented challenges to transformative changes, from the perspective of young intensivists , 2023, Annals of Intensive Care.

[3]  L. Danon,et al.  Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case–control study , 2022, The Lancet Regional Health - Europe.

[4]  A. Boehm,et al.  Prevalence of Positive Rapid Antigen Tests After 7-Day Isolation Following SARS-CoV-2 Infection in College Athletes During Omicron Variant Predominance , 2022, JAMA network open.

[5]  M. Peluso,et al.  Detection of Higher Cycle Threshold Values in Culturable SARS-CoV-2 Omicron BA.1 Sublineage Compared with Pre-Omicron Variant Specimens — San Francisco Bay Area, California, July 2021—March 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[6]  P. Austin,et al.  Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes , 2022, JAMA network open.

[7]  Man Hung,et al.  Trends in COVID-19 Inpatient Cases and Hospital Capacities during the Emergence of the Omicron Variant in the United States , 2022, COVID.

[8]  Chider Chen,et al.  The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis , 2022, Frontiers in Public Health.

[9]  J. Al-Tawfiq,et al.  De-isolation of vaccinated COVID-19 health care workers using rapid antigen detection test , 2022, Journal of Infection and Public Health.

[10]  F. Batteux,et al.  Omicron Variant in the Critical Care Units of the Paris Metropolitan Area: The Reality Research Group , 2022, American journal of respiratory and critical care medicine.

[11]  S. El-Kafrawy,et al.  Active viral shedding in a vaccinated hospitalized patient infected with the delta variant (B.1.617.2) of SARS-CoV-2 and challenges of de-isolation , 2022, Journal of Infection and Public Health.

[12]  D. Hamer,et al.  Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study , 2022, medRxiv.

[13]  M. Jozwiak,et al.  Impact of Isolation Time of COVID-19 Patients in Intensive Care Unit on Healthcare Workers Contamination and Nursing Care Intensity , 2022, Frontiers in Medicine.

[14]  M. Wise,et al.  Mechanically Ventilated Patients Shed High-Titer Live Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Extended Periods From Both the Upper and Lower Respiratory Tract , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  F. Kirchhoff,et al.  Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning? , 2022, Journal of virology.

[16]  P. Noble,et al.  Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance — One Hospital, California, July 15–September 23, 2021, and December 21, 2021–January 27, 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[17]  D. Funk,et al.  Persistence of live virus in critically ill patients infected with SARS-COV-2: a prospective observational study , 2022, Critical Care.

[18]  Mark J. Ponsford,et al.  Mechanically Ventilated Patients Shed High-Titer Live Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Extended Periods From Both the Upper and Lower Respiratory Tract , 2021, medRxiv.

[19]  L. Gieselmann,et al.  Evaluation of a Rapid Antigen Test To Detect SARS-CoV-2 Infection and Identify Potentially Infectious Individuals , 2021, Journal of clinical microbiology.

[20]  M. Malim,et al.  Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study , 2021, The Lancet Microbe.

[21]  E. Albert,et al.  Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres , 2020, Clinical Microbiology and Infection.

[22]  L. Brammer,et al.  Risk Factors for Intensive Care Unit Admission and In-hospital Mortality among Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.